TL;DR
This paper introduces a novel, automated, and high-throughput method for measuring heart rates in medaka and zebrafish embryos without anesthesia. Their "HeartBeat" software and imaging pipeline enable rapid, physiological assessment of cardiac function, paving the way for large-scale genetic screens and drug discovery.
What Problem Does This Paper Address?
Studying cardiovascular health in small fish models like medaka and zebrafish is crucial for understanding disease and testing drugs. However, existing methods for measuring their heart rates are often hindered by the need for anesthesia (which can affect heart function), laborious manual sample preparation, and the requirement for fluorescent reporters that limit genetic studies. These limitations make high-throughput analysis challenging, hindering large-scale genetic screens and drug discovery efforts.
Methods
The researchers developed a streamlined workflow that combines automated imaging with custom software. Key elements include:
- Label-Free Imaging: They use standard bright-field microscopy, eliminating the need for fluorescent reporters.
- Non-Anesthetized Embryos: Embryos are imaged in their natural physiological state, avoiding confounding effects of anesthetics.
- Random Orientation: Embryos are not meticulously positioned, simplifying sample preparation.
- Automated Microscopy: A specialized microscope system captures images of 96-well plates.
- "HeartBeat" Software: This MATLAB-based software with a graphical user interface (GUI) automatically detects and quantifies heart rate and rhythm from the acquired images. It handles segmentation of heart regions, feature extraction, and spectral analysis.
- High-Throughput Capability: The system is designed to process multiple embryos per well (up to 6), achieving a throughput of over 500 embryos per 96-well plate.
Datasets
The study utilized embryonic medaka (Oryzias latipes) and zebrafish (Danio rerio) as model organisms. No specific external datasets were used for training or evaluation; the data was generated from experiments conducted by the authors.
Key Insights and Ideas
- Physiological Conditions are Key: The ability to measure heart rate without anesthesia or special mounting is a significant step towards understanding true physiological responses.
- Temperature Matters (A Lot): Acute temperature changes dramatically impact heart rate, highlighting the critical need for precise temperature control in experimental setups to ensure reproducibility.
- Software is the Enabler: The "HeartBeat" software is central to the high-throughput nature of this assay, automating complex analysis that would otherwise be prohibitively time-consuming.
- Bright-Field is Sufficient: For many applications, especially rapid screening, bright-field imaging provides comparable results to fluorescent methods, simplifying experimental design and cost.
Key Results
- High Throughput: The assay can process over 500 embryos per 96-well plate.
- Accurate Quantification: The "HeartBeat" software demonstrated high correlation with manual counts and fluorescent readouts.
- Developmental Profiles: Detailed profiles of heart rate development from onset to hatching were established for both medaka and zebrafish.
- Temperature Sensitivity: Heart rates were shown to accelerate linearly with temperature, with zebrafish exhibiting a higher baseline and steeper response.
- Drug Screening Proof-of-Concept: The assay successfully captured concentration-dependent effects of known cardiovascular drugs (nifedipine and terfenadine), demonstrating its utility for drug discovery and toxicology. For instance, terfenadine showed concentration-dependent inhibition and AV block, while nifedipine caused rapid heart rate reduction and even asystole in zebrafish.
Limitations and Future Work
- Temperature Control: While the importance of temperature control is highlighted, maintaining precise temperatures across large-scale experiments can still be a challenge.
- AV Block Scoring: The current version of "HeartBeat" software does not explicitly score AV block, though it is reflected in the data. Future versions could incorporate this.
- Future Directions: The authors suggest that this platform is well-suited for a wide range of applications, including:
- Large-scale phenotypic screening.
- Interrogation of gene functions.
- Cardiovascular drug development pipelines.
- Toxicological assessments.
- Studies of gene x environment interactions.
Summary updated